ALLOSOURCE AND HUMACYTE CREATE BIOENGINEERED BLOOD VESSELS  |  October 10, 2013

AlloSource, a tissue bank in Colorado, and Humacyte, a regenerative medicine business from North Carolina, have partnered to create bioengineered blood vessels.

The blood vessels are being developed to provide vascular access for dialysis in End-Stage Renal Disease (ESRD) patients. This exciting technology could have the potential to help reduce or avoid surgical interventions and hospitalizations for patients with the disease.

Click HERE to read the full announcement.

Get our newsletter